Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Metabolite Panel May ID Kids With Autism Spectrum Disorder
From - Diagnostic Testing & Emerging Technologies
A group of blood metabolites help detect some children with autism spectrum disorder (ASD), according to a study published…
Rapid Molecular Testing Saves Hospitals Time, Money Ruling Out TB
...
Already a member? Log in here
Blood Test Can Cut Unnecessary Ultrasounds to Rule Out Blood Clots
...
Already a member? Log in here
Drug Testing Remains Low Among Patients on Long-Term Opioids
...
Already a member? Log in here
Diagnostics Lagging for Tickborne Infections
From - Diagnostic Testing & Emerging Technologies
The incidence of tickborne infections is on the rise in the United States. Yet, prevention and management of these infections are…
Guidelines at a Glance
...
Already a member? Log in here
Preimplantation Genetic Testing Improves IVF Outcomes
From - Diagnostic Testing & Emerging Technologies
Preimplantation genetic testing for aneuploidy (PGT-A) can mitigate the negative effects of maternal age on in vitro fertilization (IVF) outcomes by…
New Test Aids Lung Cancer Risk Assessment, But Survival Benefit of Comprehensive Sequencing Questioned
From - Diagnostic Testing & Emerging Technologies
Lung cancer-related testing is receiving a lot of attention, but recent results appear to show mixed benefits for these emerging tests…
Hidden Blood in Stool May Indicate Higher All-Cause Death Risk
From - Diagnostic Testing & Emerging Technologies
"Invisible" blood in stool may predict death from a wide range of causes, not just colorectal cancer, according to a study published July 16 in…
HBA1c Blood Test May ID Gestational Diabetes Risk in First Trimester
From - Diagnostic Testing & Emerging Technologies
First trimester HbA1c may aid in early identification of at women at risk of gestational diabetes (GD), according to a study published in Scientific Reports. Such early screening could…
